These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34432150)

  • 1. Predicting functional consequences of mutations using molecular interaction network features.
    Ozturk K; Carter H
    Hum Genet; 2022 Jun; 141(6):1195-1210. PubMed ID: 34432150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic missense protein variants affect different functional pathways and proteomic features than healthy population variants.
    Laddach A; Ng JCF; Fraternali F
    PLoS Biol; 2021 Apr; 19(4):e3001207. PubMed ID: 33909605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants.
    Iqbal S; Pérez-Palma E; Jespersen JB; May P; Hoksza D; Heyne HO; Ahmed SS; Rifat ZT; Rahman MS; Lage K; Palotie A; Cottrell JR; Wagner FF; Daly MJ; Campbell AJ; Lal D
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28201-28211. PubMed ID: 33106425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the performance of computational predictors for estimating protein stability changes upon missense mutations.
    Iqbal S; Li F; Akutsu T; Ascher DB; Webb GI; Song J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34058752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of protein-protein interactions perturbed by disease mutations.
    Cheng F; Zhao J; Wang Y; Lu W; Liu Z; Zhou Y; Martin WR; Wang R; Huang J; Hao T; Yue H; Ma J; Hou Y; Castrillon JA; Fang J; Lathia JD; Keri RA; Lightstone FC; Antman EM; Rabadan R; Hill DE; Eng C; Vidal M; Loscalzo J
    Nat Genet; 2021 Mar; 53(3):342-353. PubMed ID: 33558758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting deleterious missense genetic variants via integrative supervised nonnegative matrix tri-factorization.
    Arani AA; Sehhati M; Tabatabaiefar MA
    Sci Rep; 2021 Dec; 11(1):23747. PubMed ID: 34887492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
    Mercatanti A; Lodovichi S; Cervelli T; Galli A
    FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the use of paralogous protein domains to increase data availability for missense variant classification.
    Gunning AC; Wright CF
    Genome Med; 2023 Dec; 15(1):110. PubMed ID: 38087376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
    Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
    BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and Interpretation of the Impact of Missense Variants in Cancer.
    Petrosino M; Novak L; Pasquo A; Chiaraluce R; Turina P; Capriotti E; Consalvi V
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense variant pathogenicity predictors generalize well across a range of function-specific prediction challenges.
    Pejaver V; Mooney SD; Radivojac P
    Hum Mutat; 2017 Sep; 38(9):1092-1108. PubMed ID: 28508593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide prediction of disease variant effects with a deep protein language model.
    Brandes N; Goldman G; Wang CH; Ye CJ; Ntranos V
    Nat Genet; 2023 Sep; 55(9):1512-1522. PubMed ID: 37563329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIGMA leverages protein structural information to predict the pathogenicity of missense variants.
    Zhao H; Du H; Zhao S; Chen Z; Li Y; Xu K; Liu B; Cheng X; Wen W; Li G; Chen G; Zhao Z; Qiu G; ; Liu P; Zhang TJ; Wu Z; Wu N
    Cell Rep Methods; 2024 Jan; 4(1):100687. PubMed ID: 38211594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network-based prediction approach for cancer-specific driver missense mutations using a graph neural network.
    Hatano N; Kamada M; Kojima R; Okuno Y
    BMC Bioinformatics; 2023 Oct; 24(1):383. PubMed ID: 37817080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the functional consequences of somatic missense mutations found in tumors.
    Carter H; Karchin R
    Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein function in precision medicine: deep understanding with machine learning.
    Rost B; Radivojac P; Bromberg Y
    FEBS Lett; 2016 Aug; 590(15):2327-41. PubMed ID: 27423136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural dynamics is a determinant of the functional significance of missense variants.
    Ponzoni L; Bahar I
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4164-4169. PubMed ID: 29610305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms.
    Seifi M; Walter MA
    PLoS One; 2018; 13(4):e0195971. PubMed ID: 29664915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using PPI network autocorrelation in hierarchical multi-label classification trees for gene function prediction.
    Stojanova D; Ceci M; Malerba D; Dzeroski S
    BMC Bioinformatics; 2013 Sep; 14():285. PubMed ID: 24070402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.